Zenas BioPharma Announces First Patient Dosed in Phase 3 Clinical Study of Obexelimab for the Treatment of Immunoglobulin G4-Related Disease (IgG4-RD)
Global Phase 3 INDIGO study will evaluate the efficacy and safety of obexelimab in patients
Global Phase 3 INDIGO study will evaluate the efficacy and safety of obexelimab in patients
TEMECULA, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) — Nikkiso Clean Energy & Industrial Gases Group
FURA Gems DUBAI, United Arab Emirates, Jan. 11, 2023 (GLOBE NEWSWIRE) — FURA Gems announced
UNITED NATIONS, Jan 11 (NNN-Xinhua) — An estimated 5 million children died before their fifth
South African media have been invited to submit their entries for the 2023 SADC Media
GQEBERHA – Whenever information on crime and criminals are provided to the police, such information,
The South African National Defence Force (SANDF) says an investigation is underway into a video
Copyright © 2024 South Africa News Gazette. All Rights Reserved.